Among the four commercially available NAIs, oseltamivir and zanamivir are the predominantNAIs for influenza prophylaxis and treatment [13].Our results show that HPAI H7N9 viruses with the 292K amino acid in the NA protein exhibitedmulti-drug resistance. The gene discussed is XK; the disease is influenza.